The British Society for Rheumatology Register in Psoriatic Arthritis (BSR-PsA) tracks the progress of a cohort of patients with psoriatic arthritis who are taking one of a group of novel therapies (biologic therapies, biosimilar therapies and targeted synthetic therapies) plus a comparison cohort of patients not on these drugs.

This register is a collaboration between the University of Aberdeen and the British Society for Rheumatology.  Recruitment commenced in September 2018 and we are currently in the process of recruiting centres into the study.

You can find out more about the study at: